Hoxworth Blood Center offering free zoo tickets to blood donors
Hoxworth Blood Center, University of Cincinnati is teaming up with the Cincinnati Zoo & Botanical Garden to offer a free zoo ticket to lifesaving blood and platelet donors.
Everyone who donate at one of Hoxworth’s seven Neighborhood Donor Centers beginning Monday, April 4 through Sunday, April 24 will receive one free ticket to the Cincinnati Zoo. This incentive comes just in time to enjoy the Zoo’s Annual Tunes & Blooms Concert held each Thursday in April.
“Hoxworth is excited to partner with the Cincinnati Zoo to support our community’s blood supply,” said Alecia Lipton, spokesperson for Hoxworth Blood Center. “By donating blood later this week, donors will be able to save a life and also enjoy some time at one of Cincinnati’s most-loved attractions.”
Zoo tickets are valid through December 31, 2022. Appointments for blood donation are encouraged, but walk-ins are welcome. Donors can schedule appointments by calling (513) 451-0910 or by scheduling online at hoxworth.org.
Featured photo by Dottie Stover
About Hoxworth
Hoxworth Blood Center, University of Cincinnati, was founded in 1938 and serves more than 30 hospitals in 18 counties in Southwestern Ohio, Northern Kentucky, and Southeastern Indiana. Annually, Hoxworth collects more than 100,000 units of blood from local donors to help save the lives of patients in area hospitals. Hoxworth Blood Center: Saving Lives Close to Home.
Related Stories
Chris Higgins named UC Foundation Vice President for Development, Academic Health Enterprise
January 6, 2026
The University of Cincinnati Foundation is pleased to welcome Chris Higgins as the new Vice President for Development, Academic Health Enterprise.
What's behind the mysterious rise of migraines?
January 5, 2026
Weather patterns such as extreme heat and storm conditions have been linked to migraine attacks, and research shows those environmental conditions are becoming more common. As National Geographic recently reported, one of the leading theories behind this mysterious rise is that climate change may be playing a role.
Top six 2025 nephrology drug approvals
January 5, 2026
“2025 has been a landmark year for kidney disease therapeutics, marked by a comprehensive slate of FDA approvals covering endothelin-receptor blockade, complement inhibition, GLP-1-based metabolic protection, and B-cell-directed therapy,” Prakash Gudsoorkar, MD, associate professor of clinical medicine at the University of Cincinnati College of Medicine and staff nephrologist at UC Health, recently told MedCentral.